Amanda Fenster


Amanda Fenster is an associate in Weil’s Mergers & Acquisitions practice and is based in New York. Ms. Fenster participates in the representation of public and private companies in mergers, acquisitions and divestitures.

Ms. Fenster has been part of the teams advising*:

  • Blount International, Inc., in connection with its acquisition of SP Companies, Inc. and its wholly-owned subsidiary, SpeeCo, Incorporated
  • British American Tobacco in its $4.7 billion investment as part of Reynolds American’s $27.4 billion purchase of Lorillard and sale to Imperial Tobacco of assets and liabilities for total consideration of $7.1 billion
  • Brookfield Asset Management Inc. in its pending approximately $4.8 billion acquisition of a 62% stake in Oaktree Capital Group, LLC 
  • Ditech Holding Corporation (f/k/a Walter Investment Management Corp.) in its pending sale of Ditech Financial LLC to New Residential Investment Corp., and sale of Reverse Mortgage Solutions, Inc. to Mortgage Assets Management, LLC 
  • Eli Lilly and Company in its $7.9 billion exchange of its approximately 82% remaining interest in Elanco Animal Health Incorporated for Lilly common shares held by its shareholders
  • General Electric Company in its $2.6 billion sale of GE Industrial Solutions to ABB
  • Graham Holdings Company in connection with its $1.1 billion split-off transaction with Berkshire Hathaway
  • Heartland Dental Care, LLC in the sale, by Ontario Teachers’ Pension Plan and other existing shareholders, of a majority stake in Heartland to KKR & Co., with Ontario Teachers' retaining a sizeable ownership stake
  • IBM in connection with its acquisition of several private companies, including Lombardi Software, Initiate Systems and Bigfix, Inc.
  • InterMune, Inc. in connection with its $8.9 billion sale to Roche
  • MarkWest Energy Partners LP in connection with its $21 billion merger with MPLX LP
  • Millipore Corporation in connection with the execution of its $7.1 billion acquisition by Merck KGaA
  • Transaction Committee of the Board of Directors of Norwegian Cruise Line in the $3.025 billion acquisition of Prestige Cruises International by Norwegian
  • Ontario Teachers’ Pension Plan Board in, together with Apollo Global Management, the acquisition of a controlling interest in CareerBuilder, LLC; and in, together with L Catterton and others, the sale of PetVet Care Centers, LLC
  • Polymer Group Inc. in connection with its $325 million sale to Blackstone
  • Quest Diagnostics Inc. in its acquisition of the U.S. laboratory services business of Oxford Immunotec Global PLC
  • Sapient Corporation in connection with its $3.7 billion sale to Publicis Groupe
  • Zale Corporation in connection with its $1.4 billion sale to Signet Jewelers Limited

Ms. Fenster is recognized as a “Rising Star” for Mergers & Acquisitions by Super Lawyers. 

Prior to joining Weil, Ms. Fenster was Associate General Counsel at IDEXX Laboratories, Inc. and prior to that, an associate at an international law firm. Ms. Fenster received her J.D., cum laude, from University of Pennsylvania Law School and her B.A., cum laude, from University of Pennsylvania.

*Includes matters handled prior to joining Weil.

Awards and Recognition, Speaking Engagements, Guides and Resources, Latest Thinking, Firm News & Announcements

Awards and Recognition

Firm News & Announcements

View all